Mais de 25 anos de evidências

Venha para onde estão os especialistas

Esta página apresenta publicações e webinars de todo o mundo. Ela inclui evidências para uma ampla variedade de locais de tratamento, incluindo doenças malignas e benignas, diferentes cronogramas de fracionamento e técnicas de sincronização de movimento para as plataformas CyberKnife® e TomoTherapy®. Atualizamos novos documentos regularmente. Dedique um momento para explorar a página e ver as evidências que coletamos para demonstrar verdadeiramente como estamos mudando a vida das pessoas.

Conteúdo em destaque

MÊS DE CONSCIENTIZAÇÃO SOBRE O CÂNCER DE MAMA

Toxicidade cutânea em pacientes com câncer de mama precoce tratados com radioterapia modulada por intensidade de mama em campo versus radioterapia modulada por intensidade de mama inversa helicoidal: resultados de um estudo controlado randomizado de fase III

Data: 2021

Técnica de tratamento: IMRT helicoidal

Plataforma: TomoTherapy

Autor: K Joseph et al.

MÊS DE CONSCIENTIZAÇÃO SOBRE O CÂNCER DE MAMA

Estimativa de mortes anuais por câncer de pulmão secundário usando várias técnicas adjuvantes de radioterapia de mama para câncer em estágio inicial - PubMed (nih.gov)

Data: 2021

Técnica de tratamento: APBI

Plataforma: CyberKnife

Autor: Jean-Philippe Pignol et al.

MÊS DE CONSCIENTIZAÇÃO SOBRE O CÂNCER DE MAMA

Radioterapia adjuvante de mama total ultra-hipofracionada no cenário do mundo real: experiência única com 271 pacientes idosos/frágeis tratados com técnica 3D e IMRT - PubMed (nih.gov)

Data: 2022

Técnica de tratamento: TomoDirect

Plataforma: TomoTherapy

Autor: M Zerella et al.

Impact of CyberKnife Radiosurgery on Median Overall Survival of Various Parameters in Patients with 1-12 Brain Metastases

Stereotactic Reirradiation with CyberKnife for Locally Recurrent Prostate Cancer, Long-term Toxicity and Clinical Outcomes from a Monocentric Cohort

Francolini G, Carnevale MG, Di Cataldo V, Loi M, Detti B, Orsatti C, Caprara L, Bertini N, Lorenzetti V, Olmetto E, Becherini C, Visani L, Salvestrini V, Simontacchi G, Greto D, Bonomo P, Doro R, Masi L, Desideri I, Meattini I, Serni S, Livi L | Radiol Med | 2023

Intensity Modulated Radiation Therapy with Stereotactic Body Radiation Therapy Boost for Unfavorable Prostate Cancer: Five-year Outcomes

Carrasquilla M, Sholklapper T, Pepin AN, Hodgins N, Lei S, Rashid A, Danner M, Zwart A, Bolanos G, Ayoob M, Yung T, Aghdam N, Collins B, Suy S, Kumar D, Hankins R, Kowalczyk K, Dawson N, Collins S | Front Oncol | 2023

Accuracy of Robotic Radiosurgery in Renal Cell Carcinoma

Hofmann T, Kohlhase N, Eftimova D, Eder MM, Staehler M, Ruge MI, Muacevic A, Fürweger C | Phys Med | 2024

Revisiting Radioresistance: A Systematic Review of Outcomes of Stereotactic Radiosurgery (SRS) in Functional Head and Neck Paragangliomas

Verma O, Mantziaris G, Das L, Sheehan JP, Tripathi M | Neurosurg Rev. | 2025

Hypofractionated Radiosurgery (25 Gy/5 fractions) for Optic Nerve Sheath Meningiomas: Results from an Exploratory Phase 2 Prospective Trial

Fariselli L, Marzoli SB, Morlino S, Pinzi V, Pedone C, De Martin E, Romeo A, Tramacere I, Marchetti M | Int J Radiat Oncol Biol Phys. | 2025

Efficacy and Safety of Donut-Shaped Circumferential Spine CyberKnife Stereotactic Body Radiotherapy for Metastatic Spine Disease

Park DJ, Lee I, Annagiri S, Chou KN, Zamarud A, Akhavan-Sigari A, Hori YS, Persad AR, Abu-Reesh D, Lam FC, Tayag A, Ustrzynski L, Emrich SC, Gu X, Pollom EL, Chang SD | Neurosurgery. | 2025

Computed Tomography Guided Online Adaptive Stereotactic Body Radiation Therapy for Lymph Node Oligometastases: Impact on Dose to Target and Organs at Risk

van Werkhoven LA, Milder MTW, Schillemans W, Hoogeman MS, Nout RA, Nuyttens JJ | Int J Radiat Oncol Biol Phys. | 2025

Pattern of Recurrence After Fractionated Stereotactic Reirradiation in Adult Glioblastoma

Margulies A, Sahki N, Rech F, Vogin G, Blonski M, Peiffert D, Taillandier L, Lesanne G, Demogeot N | Radiat Oncol. | 2025

Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study

Zygogianni A, Koukourakis IM, Liakouli Z, Desse D, Georgakopoulos I, Armpilia C, Lymperopoulou G, Kouloulias V | Biomedicines. | 2025

Risk-adapted Stereotactic Body Radiation Therapy for the Treatment of Large (>3 cm) Primary Lung Cancer with or without Histologic Confirmation: A Propensity Score Matched and Weighted Analysis

Zeng HY, Li YJ, Ji CZ, Wang HH, Yu XR, He Y, Bai H, Zheng BY, Yan YY, Xu JW, Zaorsky NG, Shi JM, Dong Y, Yu XY, Wang JS, Song YC, Yuan ZY, Chen Y, Meng MB. | Radiother Oncol. | 2025

Local Control and Recurrence Patterns after Stereotactic Irradiation Delivered in more than 4 Fractions for Hepatocellular Carcinomas and liver metastases: a retrospective study

Renan A, Bruand M, Jolnerovski M, Diallo A, Demogeot N | Radiat Oncol. | 2025

Fractionated Robotic Radiosurgery for Unfavorable Nonfunctioning Pituitary Macroadenoma: 5-year Outcomes from a Single Institution Protocol

Bhatnagar A, Marin MP, Lischalk JW, Koh MJ, Agazzi S, Suy S, Harris BT, Sharma ST, Aulisi E, Anaizi A, Khattab MH, Jean WC, Collins SP, Collins BT | Front Oncol. | 2025

A Simple Plan Strategy to Optimize the Biological Effective Dose Delivered in Robotic Radiosurgery of Vestibular Schwannomas

Moutsatsos A, Pantelis E | Phys Med Biol. | 2025

Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study

Ratnakumaran R, Sasitharan A, Khan A, Mayet H, Mohajer J, Hinder V, Brand DH, Fullarton R, Loblaw A, Hall E, van As N, Tree AC; PACE trial investigators | Int J Radiat Oncol Biol Phys. | 2025